2018 Presentation Slides – Quantitative Imaging Workshop

Biomarkers and Drug Development: Regulatory Perspective 
Christopher Leptak, MD, PhD, Director, DCER Biomarker Qualification Program, U.S. Food & Drug Administration

Towards an International Image Quality Monitoring Framework for Quantitative Imaging: Plan for Global Sharing and Progress 
Ricardo S. Avila, MS, Accumetra, LLC

Use of Phantoms and Image Datasets for Regulatory Decision Making
Nicholas Petrick. Ph.D., U.S. Food and Drug Administration (FDA)

VA Partnership to Increase Access to Lung Screening 
Claudia Henschke, PhD, MD, Icahn School of Medicine at Mount Sinai 

Equity Issues with Lung Cancer Screening 
Mary Pasquinelli, MS, APRN, FNP-BC, UI Health

Lung Cancer, COPD and Cardiovascular Disease – Quality is a Gateway to Deep Learning 
James L. Mulshine, MD, Rush University

COPD and Early Interception of Lung Cancer 
George Washko, MD, Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital

Early Assessment of Interstitial Lung Disease: Opportunities in Lung Cancer Screening 
Mary Salvatore MD, MBA, Columbia University Medical Center 

CT Lung Screening Implementation Challenges: ALA/ATS Implementation Microsite 
Andrea McKee, MD, Lahey Hospital and Medical Center

Imaging Advances in Smoking-related Injury: From COPD to Interstitial Lung Disease 
Raúl San José Estépar, PhD, Applied Chest Imaging Laboratory, Brigham and Women’s Hospital 

Project ECHO® (Extension for Community Health Outcomes) 
Sanjeev Arora, MD, FACG, MACP, University of New Mexico – Project ECHO

Return to Quantitative Imaging Workshop main page 

Sign up to get the latest about cancer prevention and early detection directly in your inbox.